RARE

NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$19.87

-0.55 (-2.69%)

As of Mar 22, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 25 93%

Hold 2 7%

Sell 0 0%

Price Target

Analyst Price Target +274.6% upside

Low Target $68.49

Average Target $74.44

High Target $103.74

Current Price $19.87

Current
$19.87

Target
$74.44

$68.49 $74.44 avg $103.74

Scenario Analysis

Bear Case

$68.49

244.7%

Low target

Base Case

$74.44

+274.6%

Avg target

Bull Case

$103.74

+422.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$45.00

-55.8% from high

52-Week Low

$18.41

+7.9% from low

50-Day SMA

$26.56

-25.2% vs SMA

200-Day SMA

$31.06

-36.0% vs SMA

RSI (14)

37.4

Neutral

Target vs 52W High

$74.44

+65.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%